Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1246457.RAx9HXYkFUbHVGe5t0lORETxNolAJKJ4weNEP3OhL9nwE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1246457.RAx9HXYkFUbHVGe5t0lORETxNolAJKJ4weNEP3OhL9nwE130_assertion type Assertion NP1246457.RAx9HXYkFUbHVGe5t0lORETxNolAJKJ4weNEP3OhL9nwE130_head.
- NP1246457.RAx9HXYkFUbHVGe5t0lORETxNolAJKJ4weNEP3OhL9nwE130_assertion description "[These studies have prompted the use of PARP inhibitors to treat BRCA1 and BRCA2-deficient ovarian cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246457.RAx9HXYkFUbHVGe5t0lORETxNolAJKJ4weNEP3OhL9nwE130_provenance.
- NP1246457.RAx9HXYkFUbHVGe5t0lORETxNolAJKJ4weNEP3OhL9nwE130_assertion evidence source_evidence_literature NP1246457.RAx9HXYkFUbHVGe5t0lORETxNolAJKJ4weNEP3OhL9nwE130_provenance.
- NP1246457.RAx9HXYkFUbHVGe5t0lORETxNolAJKJ4weNEP3OhL9nwE130_assertion SIO_000772 25490527 NP1246457.RAx9HXYkFUbHVGe5t0lORETxNolAJKJ4weNEP3OhL9nwE130_provenance.
- NP1246457.RAx9HXYkFUbHVGe5t0lORETxNolAJKJ4weNEP3OhL9nwE130_assertion wasDerivedFrom befree-2016 NP1246457.RAx9HXYkFUbHVGe5t0lORETxNolAJKJ4weNEP3OhL9nwE130_provenance.
- NP1246457.RAx9HXYkFUbHVGe5t0lORETxNolAJKJ4weNEP3OhL9nwE130_assertion wasGeneratedBy ECO_0000203 NP1246457.RAx9HXYkFUbHVGe5t0lORETxNolAJKJ4weNEP3OhL9nwE130_provenance.